Dalrada Financial CORP: management transactions · United States · SEC (Form 4)

About Dalrada Financial CORP

Dalrada Financial Corporation (ticker DFCO) is a U.S.-based public company whose latest filings and investor materials indicate OTC trading status rather than an active NYSE/NASDAQ listing in the sources reviewed. For investors, the company is best understood as a diversified operating holding company with exposure to industrial, technology, healthcare, and clean-energy themes, despite its financial-sounding corporate name. Dalrada was originally incorporated in September 1982 in California, later reincorporated in Delaware, and then reincorporated in Wyoming on May 5, 2020. Its principal executive offices are in Escondido, California, and its filings and corporate communications describe a broader operating footprint across the United States and internationally. ([sec.gov](https://www.sec.gov/Archives/edgar/data/725394/000168316822001440/dalrada_s1.htm?utm_source=openai)) The group currently organizes its business around five divisions: Genefic, Dalrada Climate Technology, Dalrada Precision Manufacturing, Dalrada Technologies, and Dalrada Corporate. Genefic focuses on healthcare-related solutions including diagnostics, pharmaceutical products, and wellness services. Dalrada Climate Technology is centered on decarbonization and energy-efficiency products, including heat-pump and related climate solutions. Dalrada Precision Manufacturing develops precision manufacturing capabilities, while Dalrada Technologies houses IT and advanced-technology offerings. In practice, this makes Dalrada a multi-vertical platform rather than a single-line operating company. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0000725394/000168316825007318/dalrada_i10k-063025.htm?utm_source=openai)) From a competitive standpoint, Dalrada operates in specialized niches where execution, product commercialization, and the ability to scale engineered solutions are critical. Recent company communications emphasize core end markets such as clean energy, high-efficiency heating and cooling systems, atmospheric water generation, and semiconductor thin-film deposition. In November 2024, the company announced a new manufacturing and R&D facility in Portland, Oregon for Deposition Technology USA, describing it as a new U.S. headquarters and a way to support growing North American demand. That move signals an effort to strengthen its domestic industrial base and deepen its presence in advanced manufacturing. ([dalrada.com](https://dalrada.com/dalrada-establishes-deposition-technology-usa-presence-with-new-portland-facility/?utm_source=openai)) At the same time, the latest SEC annual report for the fiscal year ended June 30, 2025 highlights material financial risk. The filing states that the company has suffered recurring operating losses and has a net capital deficiency that raises substantial doubt about its ability to continue as a going concern. Dalrada’s January 2026 shareholder letter, referenced in an SEC filing, said the company made operational progress in renewable-energy/heat-pump products, atmospheric water generators, and semiconductor deposition solutions, while also highlighting partnerships, installations, and restructuring efforts. However, the sources reviewed do not provide enough audited evidence to confirm a durable financial turnaround. Overall, DFCO remains a high-risk, event-driven equity story tied to industrial transformation, but with meaningful balance-sheet and execution risk. ([sec.gov](https://www.sec.gov/Archives/edgar/data/725394/000168316825007318/dalrada_i10k-063025.htm))